Cecile Le Pechoux Selected Research

Radiation Pneumonitis

1/2017

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cecile Le Pechoux Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2013
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2020 - 09/2011
5	Lung Neoplasms (Lung Cancer) 04/2021 - 10/2013
4	Neoplasms (Cancer) 11/2021 - 07/2015
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2021
3	Infections 01/2022 - 01/2020
2	COVID-19 01/2020 - 01/2020
1	Sepsis (Septicemia) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Margins of Excision 11/2021
1	Thoracic Diseases 01/2019
1	Radiation Pneumonitis 01/2017
1	Neutropenia 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 07/2015

Drug/Important Bio-Agent (IBA)

1	durvalumabIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	brigatinibIBA 11/2018

Therapy/Procedure

20	Radiotherapy 01/2022 - 09/2011
8	Cranial Irradiation 01/2022 - 09/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
3	Adjuvant Chemotherapy 11/2021 - 03/2015
2	Chemoradiotherapy 01/2017 - 12/2015
1	Induction Chemotherapy 11/2021
1	Re-Irradiation 12/2014